Injection site spot; similar to bursitis/  possible bursitis; shoulder pain (in injected arm) which radiated and caused lack of mobility; shoulder pain / pain in the upper part of the arm /  forearm and into her thumb; pain in the upper part of the arm /  forearm and into her thumb; which radiated and caused lack of mobility; pain under the arm.; difficult for her to put on her car seatbelt/ affected her mobility with respect to dressing herself / no longer reach behind her back to tie the apron; This case was reported by a consumer via call center representative and described the occurrence of injected limb mobility decreased in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number 9974P, expiry date 9th May 2022) and (batch number CD9MZ, expiry date 9th May 2022) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID 19 VACCINE) for prophylaxis.   The patient's past medical history included bursitis (had bursitis about one year ago and about 10 to 11 years before that).   On 28th December 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, the dose was an unknown dose. On an unknown date, the patient received COVID 19 VACCINE. In December 2020, less than a week after receiving Shingrix, the patient experienced injected limb mobility decreased, shoulder pain, pain in arm, radiating pain, bursitis, axillary pain and activities of daily living impaired. On an unknown date, the patient experienced injection site discoloration. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the injected limb mobility decreased, shoulder pain, pain in arm, radiating pain, bursitis, axillary pain and activities of daily living impaired were not recovered/not resolved and the outcome of the injection site discoloration was unknown.   It was unknown if the reporter considered the injected limb mobility decreased, shoulder pain, pain in arm, radiating pain, bursitis, axillary pain and activities of daily living impaired to be related to Shingrix.  Additional details were provided as follows: The reporter reported for herself. The patient received dose of Shingrix in the left deltoid. The patient received covid 19 vaccine in the right arm. The reporter stated that, a day or two after the Shingrix shot, the patient experiencing shoulder pain in the left shoulder similar to bursitis. The patient stated that, the pain had been in different areas of the shoulder and had made it difficult for her to put on her car seatbelt. It had also affected her mobility with respect to dressing herself (putting on pajamas) and it was painful to wear an apron because she could no longer reach behind her back to tie the apron herself. The pain gradually got worse and spread to the shoulder and pain in the upper part of the arm, and the back of the arm, and under the arm, then the pain also radiated down into her forearm and into her thumb. The patient had not reported this to her primary care physician yet. The patient did make an appointment with her orthopedic doctor but she postponed the appointment because she was concerned that they might give her a cortisone injection and she had an appointment to get a Covid-19 vaccine and was concerned that a cortisone injection might interfere with the Covid19 vaccine. The patient received covid 19 vaccine in the opposite arm (the right arm) and got a little spot on her arm at the injection site. The patient received extra strength Tylenol (twice a day) every day as a treatment. Till the time of reporting, the patient feels a little less than it had been for the past month. It was dissipating on the day of reporting. The reporter consented to follow up.